Literature DB >> 17895302

Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus.

V Barkauskaite1, M Ek, K Popovic, H E Harris, M Wahren-Herlenius, F Nyberg.   

Abstract

HMGB1 is a pro-inflammatory cytokine that together with TNF-alpha and IL-1beta is involved in the pathogenesis of spontaneously occurring skin lesions in lupus erythematosus. The purpose of the present study was to explore the sequence of events in HMGB1, TNF-alpha and IL-1beta expression under development and resolution of experimentally induced CLE lesions. The study involved investigation of 38 serial skin biopsies acquired from photoprovoked skin lesions of nine CLE patients, using immunohistochemical staining of tissue sections. In biopsies from the clinically most active phase of skin involvement extracellular, secreted HMGB1 and increased cytoplasmic HMGB1 were found, as compared with the late and fading lesions or non-lesional skin. Besides HMGB1, increased expression of TNF-alpha and IL-1beta was observed in dermal infiltrates of the induced CLE lesions. These cytokines were however not upregulated in all lesions, and increased expression of IL-1beta was seen predominantly in late biopsies.In conclusion, extracellular and cytoplasmic HMGB1 coincides with the clinically most active phase of photoinduced lesions of cutaneous lupus, and suggests that HMGB1 is an important factor in the inflammatory autoimmune process of CLE. HMGB1 can induce expression of TNF-alpha and IL-1beta, and formation of a pro-inflammatory loop between HMGB1, TNF-alpha, and IL-1beta may be responsible for the prolonged and sustained inflammation in CLE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17895302     DOI: 10.1177/0961203307081895

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  30 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

2.  The alarmin HMGB-1 influences healing outcomes in fetal skin wounds.

Authors:  Adrienne D Dardenne; Brian C Wulff; Traci A Wilgus
Journal:  Wound Repair Regen       Date:  2013-02-25       Impact factor: 3.617

3.  Effect of different 1, 25-(OH)2D3 doses on high mobility group box1 and toll-like receptors 4 expression in lung tissue of asthmatic mice.

Authors:  Junying Qiao; Bin Luan; Huiru Gu; Yanli Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  HMGB1 is a therapeutic target for sterile inflammation and infection.

Authors:  Ulf Andersson; Kevin J Tracey
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Prioritization of genes involved in endothelial cell apoptosis by their implication in lymphedema using an analysis of associative gene networks with ANDSystem.

Authors:  Olga V Saik; Vadim V Nimaev; Dilovarkhuja B Usmonov; Pavel S Demenkov; Timofey V Ivanisenko; Inna N Lavrik; Vladimir A Ivanisenko
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

6.  Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury.

Authors:  Xiaoping Qing; Milena Pitashny; David B Thomas; Franck J Barrat; Mark P Hogarth; Chaim Putterman
Journal:  Immunol Lett       Date:  2008-09-24       Impact factor: 3.685

7.  Baicalin Protects Keratinocytes from Toll-like Receptor-4 Mediated DNA Damage and Inflammation Following Ultraviolet Irradiation.

Authors:  Wei Min; Israr Ahmad; Michelle E Chang; Erin M Burns; Qihong Qian; Nabiha Yusuf
Journal:  Photochem Photobiol       Date:  2015-09-11       Impact factor: 3.421

Review 8.  Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.

Authors:  Ben Lu; Ce Wang; Mao Wang; Wei Li; Fangping Chen; Kevin J Tracey; Haichao Wang
Journal:  Expert Rev Clin Immunol       Date:  2014-04-19       Impact factor: 4.473

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 10.  Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.

Authors:  Fleur Schaper; Johanna Westra; Marc Bijl
Journal:  Mol Med       Date:  2014-03-13       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.